| [1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29.
|
| [2] |
Zheng Y, Wu CX, Zhang ML. The epidemic and characteristics of female breast cancer in China[J]. Zhongguo Ai Zheng Za Zhi, 20 13, 23(8): 561-9. [郑莹, 吴春晓, 张敏璐. 乳腺癌在中国的流 行状况和疾病特征[J]. 中国癌症杂志, 2013, 23(8): 561-9.]
|
| [3] |
Ren J. Molecular targeted therapy for breast cancer[J]. Zhongguo Shi Yong Nei Ke Za Zhi, 2007, 27(24): 1907-10. [任军. 乳腺癌的 分子靶向治疗[J]. 中国实用内科杂志, 2007, 27(24): 1907-10.]
|
| [4] |
Hong Y. The research progress of triple negative breast cancer[J]. Zhongguo Zhong Liu Lin Chuang Yu Kang Fu, 2012, 19(1): 92-3. [洪勇. 三阴性乳腺癌研究进展[J]. 中国肿瘤临床与康复, 2012, 19 (1): 92-3.]
|
| [5] |
Hao SP, Liu HQ. COX analysis of prognostic factors in 60 patients with gastric carcinoma[J]. Zhongguo Yao Wu Yu Lin Chuang, 20 10, 10(12): 1378-79. [郝世平, 刘鸿齐. 胃癌根治术60例预后 因素的COX分析[J]. 中国药物与临床, 2010, 10(12): 1378-79.]
|
| [6] |
Karavitis J, Zhang M. COX2 regulation of breast cancer bone metastasis[J]. Oncoimmunology, 2013, 2(3): e23129.
|
| [7] |
Tyagi A, Agarwal C, Dwyer-Nield LD, et al. Silibinin modulates TNF-alpha and IFN-gamma mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells[J]. Mol Carcinog, 2012, 51(10): 832-42.
|
| [8] |
Su S, Chen X, Jiang K, et al. Expression of CDX2, COX-2, and NF-κB in gastric carcinoma and precancerous lesions[J]. Zhongguo Zhong Liu Lin Chuang, 2013, 40(22): 1387-90. [苏帅, 陈鑫, 姜葵, 等. CDX2、COX-2和NF-κB在胃癌和癌前病变中 的表达和意义[J]. 中国肿瘤临床, 2013, 40(22): 1387-90.]
|
| [9] |
Zhou X, Xia Y, Li L, et al. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2[J]. Cancer Biol Ther, 2015, 16(1): 160-9.
|
| [10] |
Li G, Xu J, Wang Z, et al. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients[J]. J Cancer Res Clin Oncol, 2015, 141(3): 443-52.
|
| [11] |
Farh KK, Grimson A, Jan C, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution[J]. Science, 2005, 310(5755): 1817-21.
|
| [12] |
Ayyildiz T, Dolar E, Adim SB, et al. Lack of prognostic significance of SOCS-1 expression in colorectal adenocarcinomas[J]. Asian Pac J Cancer Prev, 2014, 15(19): 8469-74.
|
| [13] |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-97.
|
| [14] |
Mets E, Van der Meulen J, Van Peer G, et al. MicroRNA-193b- 3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia[J]. Leukemia, 2015, 29(4): 79 8-806.
|
| [15] |
Mueller M, Zhou J, Yang L, et al. PreImplantation factor promotes neuroprotection by targeting microRNA let-7[J]. Proc Natl Acad Sci U S A, 2014, 111(38): 13882-7.
|
| [16] |
Chakrabarty A, Tranguch S, Daikoku T, et al. MicroRNA regulation of cyclooxygenase-2 during embryo implantation[J]. Proc Natl Acad Sci U S A, 2007, 104(38): 15144-9.
|
| [17] |
Galam L, Parthasarathy PT, Cho Y, et al. Adenovirus-mediated transfer of the SOCS-1 gene to mouse lung Confers protection against hyperoxic acute lung injury[J]. Free Radic Biol Med, 20 15, 84: 196-205.
|
| [18] |
Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J]. Cancer Res, 2000, 60(5): 1306-11.
|
下载:
